Pharma Journalist -

Avita Medical Limited filed an IPR (Inter Partes Review) petition against US Patent No. 9,610,430 owned by Renovacare Sciences and request that all claim in the patent should be…
Read More...

LENSAR and PDL BioPharma announced the completion of LENSAR's financial restructuring with a court-approved exit plan finalized on May 11, 2017.   As part of the plan, PDL will convert…
Read More...

Catalent Pharma Solutions announced that it will commercially manufacture Lexicon Pharmaceuticals, XERMELO following the FDA  approval at its Kansas City facility. XERMELO…
Read More...

INC Research and inVentiv Health announced that their Boards of Directors have  approved a definitive merger agreement pursuant to which their businesses would combine in an all-stock…
Read More...

Proteon Therapeutics announced that FDA has awarded Breakthrough Therapy Designation to vonapanitase (investigational treatment) for increasing arteriovenous fistula secondary patency…
Read More...

Takeda Pharmaceutical signed contract with GammaDelta Therapeutics for collaboration to develop GammaDelta Therapeutics' novel T cell platform based on the unique properties of gamma…
Read More...

ANI Pharmaceuticals, Inc. announced the launch of its first Pindolol Tablets, 5mg and 10mg. ANI's President and CEO, Arthur S. Przybyl said that they are excited to launch the first…
Read More...

BioAtla, announced that Dr. Yong Ben has been appointed as Chief Medical Officer. Dr. Yong Ben joins BioAtla with over 20 years of industry and academic experience in oncology.…
Read More...

DURECT announced that it has signed a $293 Million Agreement with Sandoz to develop and market DURECT's POSIMIR (SABER-Bupivacaine) in the United States. According to the terms of…
Read More...

Cosmo Pharmaceuticals announced that clinical trial of Eleview in comparison to a standard saline solution in subjects undergoing Endoscopic Mucosal Resection (EMR) of colonic lesions…
Read More...